{"DataElement":{"publicId":"6620591","version":"4","preferredName":"Microscopic Examination Short Name","preferredDefinition":"A character or string that represents the short code name of the microscopic findings assessment.","longName":"MITESTCD","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6620585","version":"1","preferredName":"Microscopic Findings Domain Microscopic Findings Test Code","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings._A character or string that represents the short code name of the microscopic findings assessment.","longName":"6407670v1.0:6620583v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407670","version":"1","preferredName":"Microscopic Findings Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","longName":"C95095","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Findings Domain","conceptCode":"C95095","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3D377-A300-2627-E053-F662850A04B0","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6620583","version":"1","preferredName":"Microscopic Findings Test Code","preferredDefinition":"A character or string that represents the short code name of the microscopic findings assessment.","longName":"C117577","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Findings Test Code","conceptCode":"C117577","definition":"A character or string that represents the short code name of the microscopic findings assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80AF6AF2-F89A-41DF-E053-F662850AA732","latestVersionIndicator":"Yes","beginDate":"2019-01-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-30","modifiedBy":"ONEDATA","dateModified":"2019-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"80AF6AF2-F8AB-41DF-E053-F662850AA732","latestVersionIndicator":"Yes","beginDate":"2019-01-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-30","modifiedBy":"SOKKERL","dateModified":"2022-02-08","changeDescription":"1-30-19 Created for SDTM standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6618619","version":"1.3","preferredName":"CDISC SDTM Microscopic Findings Test Code Terminology Code","preferredDefinition":"Terminology associated with the SDTM microscopic findings test code codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"MITSCD","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BANFRDX","valueDescription":"Banff Renal Diagnostic Category Assessment","ValueMeaning":{"publicId":"6422520","version":"1","preferredName":"Banff Renal Diagnostic Category Assessment","longName":"6422520","preferredDefinition":"The histologic evaluation and diagnosis of the type of renal allograft rejection based on kidney biopsies and the Banff Working Classification from the Banff Foundation for Allograft Pathology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Banff Renal Diagnostic Category Assessment","conceptCode":"C135464","definition":"The histologic evaluation and diagnosis of the type of renal allograft rejection based on kidney biopsies and the Banff Working Classification from the Banff Foundation for Allograft Pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1B7A-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB1-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BD2","valueDescription":"Beta-defensin 2 Measurement","ValueMeaning":{"publicId":"6404283","version":"1","preferredName":"Beta-defensin 2 Measurement","longName":"6404283","preferredDefinition":"The determination of the amount of beta-defensin 2 in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beta-defensin 2 Measurement","conceptCode":"C122102","definition":"The determination of the amount of beta-defensin 2 in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E14734-4946-6DDA-E053-F662850AD5ED","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB2-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BDKRB1","valueDescription":"Bradykinin Receptor B1 Measurement","ValueMeaning":{"publicId":"6422518","version":"1","preferredName":"Bradykinin Receptor B1 Measurement","longName":"6422518","preferredDefinition":"The determination of the amount of bradykinin receptor B1 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bradykinin Receptor B1 Measurement","conceptCode":"C139099","definition":"The determination of the amount of bradykinin receptor B1 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1B49-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB3-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BRCA1","valueDescription":"Breast Cancer Type 1 Susceptibility Protein Measurement","ValueMeaning":{"publicId":"6422516","version":"1","preferredName":"Breast Cancer Type 1 Susceptibility Protein Measurement","longName":"6422516","preferredDefinition":"The determination of the amount of breast cancer type 1 susceptibility protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer Type 1 Susceptibility Protein Measurement","conceptCode":"C123555","definition":"The determination of the amount of breast cancer type 1 susceptibility protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1B23-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB4-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CDX2AG","valueDescription":"CDX2 Antigen Measurement","ValueMeaning":{"publicId":"6422512","version":"1","preferredName":"CDX2 Antigen Measurement","longName":"6422512","preferredDefinition":"The determination of the amount of CDX2 antigen present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDX2 Antigen Measurement","conceptCode":"C139098","definition":"The determination of the amount of CDX2 antigen present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1AD7-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB5-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CELLDIFF","valueDescription":"Cellular Differentiation Assessment","ValueMeaning":{"publicId":"6422510","version":"1","preferredName":"Cellular Differentiation Assessment","longName":"6422510","preferredDefinition":"The determination of the amount of cellular differentiation in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Differentiation Assessment","conceptCode":"C132430","definition":"The determination of the amount of cellular differentiation in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1AB1-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB6-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CY16","valueDescription":"Cytokeratin 16 Measurement","ValueMeaning":{"publicId":"6422508","version":"1","preferredName":"Cytokeratin 16 Measurement","longName":"6422508","preferredDefinition":"The determination of the amount of cytokeratin 16 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokeratin 16 Measurement","conceptCode":"C127763","definition":"The determination of the amount of cytokeratin 16 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1A8B-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB7-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"DCLAMP","valueDescription":"Dendritic Cell Lysosomal-Associated Membrane Protein Measurement","ValueMeaning":{"publicId":"6422506","version":"1","preferredName":"Dendritic Cell Lysosomal-Associated Membrane Protein Measurement","longName":"6422506","preferredDefinition":"The determination of the amount of dendritic cell lysosomal-associated membrane protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dendritic Cell Lysosomal-Associated Membrane Protein Measurement","conceptCode":"C127764","definition":"The determination of the amount of dendritic cell lysosomal-associated membrane protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1A65-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB8-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ESTRCPT","valueDescription":"Estrogen Receptor Measurement","ValueMeaning":{"publicId":"6401894","version":"1","preferredName":"Estrogen Receptor Measurement","longName":"6401894","preferredDefinition":"The determination of the amount of estrogen receptor present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Measurement","conceptCode":"C112274","definition":"The determination of the amount of estrogen receptor present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7394635A-5AFC-1A96-E053-F662850A9FDB","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCB9-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"FIBROSIS","valueDescription":"Fibrosis Assessment","ValueMeaning":{"publicId":"6422553","version":"1","preferredName":"Fibrosis Assessment","longName":"6422553","preferredDefinition":"An evaluation of the presence or degree of fibrosis present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis Assessment","conceptCode":"C127765","definition":"An evaluation of the presence or degree of fibrosis present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CF12-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCBA-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"FOLH1","valueDescription":"Folate Hydrolase 1 Measurement","ValueMeaning":{"publicId":"6422551","version":"1","preferredName":"Folate Hydrolase 1 Measurement","longName":"6422551","preferredDefinition":"The determination of the amount of folate hydrolase 1 in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Folate Hydrolase 1 Measurement","conceptCode":"C132431","definition":"The determination of the amount of folate hydrolase 1 in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CEEC-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCBB-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GLOMLTIS","valueDescription":"Glomerulitis Assessment","ValueMeaning":{"publicId":"6422549","version":"1","preferredName":"Glomerulitis Assessment","longName":"6422549","preferredDefinition":"An evaluation of the presence or degree of glomerulitis present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glomerulitis Assessment","conceptCode":"C135465","definition":"An evaluation of the presence or degree of glomerulitis present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CEC6-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCBC-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GLOMPATH","valueDescription":"Glomerulopathy Assessment","ValueMeaning":{"publicId":"6422547","version":"1","preferredName":"Glomerulopathy Assessment","longName":"6422547","preferredDefinition":"An evaluation of the presence or degree of glomerulopathy present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glomerulopathy Assessment","conceptCode":"C135466","definition":"An evaluation of the presence or degree of glomerulopathy present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CEA0-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCBD-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"HER2","valueDescription":"Human Epidermal Growth Factor Receptor 2 Measurement","ValueMeaning":{"publicId":"4577520","version":"1","preferredName":"Human Epidermal Growth Factor Receptor 2 Measurement","longName":"4577520","preferredDefinition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Epidermal Growth Factor Receptor 2 Measurement","conceptCode":"C112312","definition":"The determination of the amount of human epidermal growth factor receptor 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0783B094-76DA-BD19-E050-BB89AD4362D6","latestVersionIndicator":"Yes","beginDate":"2014-11-10","endDate":null,"createdBy":"BONANNIR","dateCreated":"2014-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCBE-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"INTSFBRO","valueDescription":"Interstitial Fibrosis Assessment","ValueMeaning":{"publicId":"6422545","version":"1","preferredName":"Interstitial Fibrosis Assessment","longName":"6422545","preferredDefinition":"An evaluation of the presence or degree of interstitial fibrosis present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interstitial Fibrosis Assessment","conceptCode":"C135468","definition":"An evaluation of the presence or degree of interstitial fibrosis present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CE6F-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCBF-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"INTMART","valueDescription":"Intimal Arteritis Assessment","ValueMeaning":{"publicId":"6422543","version":"1","preferredName":"Intimal Arteritis Assessment","longName":"6422543","preferredDefinition":"An evaluation of the presence or degree of intimal arteritis present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intimal Arteritis Assessment","conceptCode":"C135467","definition":"An evaluation of the presence or degree of intimal arteritis present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CE49-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC0-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"IENFDEN","valueDescription":"Intraepidermal Nerve Fiber Density","ValueMeaning":{"publicId":"6422541","version":"1","preferredName":"Intraepidermal Nerve Fiber Density","longName":"6422541","preferredDefinition":"An evaluation of intraepidermal nerve fiber density present in a specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraepidermal Nerve Fiber Density","conceptCode":"C142347","definition":"An evaluation of intraepidermal nerve fiber density present in a specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CE23-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC1-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"KI67","valueDescription":"Ki67 Measurement","ValueMeaning":{"publicId":"6422539","version":"1","preferredName":"Ki67 Measurement","longName":"6422539","preferredDefinition":"The determination of the amount of Ki-67 protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ki67 Measurement","conceptCode":"C123557","definition":"The determination of the amount of Ki-67 protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CDFD-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC2-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LCN2","valueDescription":"Lipocalin-2 Measurement","ValueMeaning":{"publicId":"6401940","version":"1","preferredName":"Lipocalin-2 Measurement","longName":"6401940","preferredDefinition":"The determination of the amount of lipocalin-2 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipocalin-2 Measurement","conceptCode":"C106539","definition":"The determination of the amount of lipocalin-2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7394E67C-5002-136A-E053-F662850A3EC6","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC3-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LYMPHINV","valueDescription":"Lymphatic Invasion Assessment","ValueMeaning":{"publicId":"6422537","version":"1","preferredName":"Lymphatic Invasion Assessment","longName":"6422537","preferredDefinition":"An evaluation of the presence or degree of lymphatic invasion present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphatic Invasion Assessment","conceptCode":"C127766","definition":"An evaluation of the presence or degree of lymphatic invasion present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CDCC-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC4-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MSNGMTRX","valueDescription":"Mesangial Matrix Assessment","ValueMeaning":{"publicId":"6422535","version":"1","preferredName":"Mesangial Matrix Assessment","longName":"6422535","preferredDefinition":"An evaluation of the presence or degree of mesangial matrix present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesangial Matrix Assessment","conceptCode":"C135471","definition":"An evaluation of the presence or degree of mesangial matrix present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CDA6-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC5-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MIEXAM","valueDescription":"Microscopic Examination","ValueMeaning":{"publicId":"6422533","version":"1","preferredName":"Microscopic Examination","longName":"6422533","preferredDefinition":"An assessment by microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Examination","conceptCode":"C90424","definition":"An assessment by microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CD80-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC6-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MMRPINTP","valueDescription":"Mismatch Repair Proteins Interpretation","ValueMeaning":{"publicId":"6422532","version":"1","preferredName":"Mismatch Repair Proteins Interpretation","longName":"6422532","preferredDefinition":"The determination of the meaning of multiple mismatch repair protein assessments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair Proteins Interpretation","conceptCode":"C139093","definition":"The determination of the meaning of multiple mismatch repair protein assessments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CD5D-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC7-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MITOFIG","valueDescription":"Mitotic Figure Assessment","ValueMeaning":{"publicId":"6422530","version":"1","preferredName":"Mitotic Figure Assessment","longName":"6422530","preferredDefinition":"An evaluation of the presence or degree of mitotic figures present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Figure Assessment","conceptCode":"C135470","definition":"An evaluation of the presence or degree of mitotic figures present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CD37-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC8-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MCINTINF","valueDescription":"Mononuclear Cell Interstitial Inflammation Assessment","ValueMeaning":{"publicId":"6422528","version":"1","preferredName":"Mononuclear Cell Interstitial Inflammation Assessment","longName":"6422528","preferredDefinition":"An evaluation of the presence or degree of mononuclear cell interstitial inflammation present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mononuclear Cell Interstitial Inflammation Assessment","conceptCode":"C135469","definition":"An evaluation of the presence or degree of mononuclear cell interstitial inflammation present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494421F-CD11-4404-E053-F662850AB142","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCC9-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MLH1","valueDescription":"MutL Homolog 1 Measurement","ValueMeaning":{"publicId":"6422596","version":"1","preferredName":"MutL Homolog 1 Measurement","longName":"6422596","preferredDefinition":"The determination of the amount of MutL homolog 1 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MutL Homolog 1 Measurement","conceptCode":"C139094","definition":"The determination of the amount of MutL homolog 1 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EC81-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCCA-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MSH2","valueDescription":"MutS Homolog 2 Measurement","ValueMeaning":{"publicId":"6422594","version":"1","preferredName":"MutS Homolog 2 Measurement","longName":"6422594","preferredDefinition":"The determination of the amount of MutS homolog 2 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MutS Homolog 2 Measurement","conceptCode":"C139095","definition":"The determination of the amount of MutS homolog 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EC5B-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCCB-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MSH6","valueDescription":"MutS Homolog 6 Measurement","ValueMeaning":{"publicId":"6422592","version":"1","preferredName":"MutS Homolog 6 Measurement","longName":"6422592","preferredDefinition":"The determination of the amount of MutS homolog 6 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MutS Homolog 6 Measurement","conceptCode":"C139096","definition":"The determination of the amount of MutS homolog 6 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EC35-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCCC-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GZMB","valueDescription":"Granzyme B Measurement","ValueMeaning":{"publicId":"7165787","version":"1","preferredName":"Granzyme B Measurement","longName":"7165787","preferredDefinition":"The determination of the amount of granzyme B present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granzyme B Measurement","conceptCode":"C166073","definition":"The determination of the amount of granzyme B present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E3ABFD8-64A0-68BB-E053-F662850AEF1D","latestVersionIndicator":"Yes","beginDate":"2020-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-02-10","modifiedBy":"ONEDATA","dateModified":"2020-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCCD-4085-E063-731AD00A53CD","beginDate":"2020-04-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"FOXP3","valueDescription":"Forkhead Box Protein P3 Measurement","ValueMeaning":{"publicId":"7165789","version":"1","preferredName":"Forkhead Box Protein P3 Measurement","longName":"7165789","preferredDefinition":"The determination of the amount of forkhead box protein 3 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Forkhead Box Protein P3 Measurement","conceptCode":"C166072","definition":"The determination of the amount of forkhead box protein 3 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E3ABFD8-64C6-68BB-E053-F662850AEF1D","latestVersionIndicator":"Yes","beginDate":"2020-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-02-10","modifiedBy":"ONEDATA","dateModified":"2020-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCCE-4085-E063-731AD00A53CD","beginDate":"2020-04-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TGFB1","valueDescription":"Transforming Growth Factor Beta 1 Measurement","ValueMeaning":{"publicId":"6408905","version":"1","preferredName":"Transforming Growth Factor Beta 1 Measurement","longName":"6408905","preferredDefinition":"The determination of the amount of transforming growth factor Beta 1 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transforming Growth Factor Beta 1 Measurement","conceptCode":"C117861","definition":"The determination of the amount of transforming growth factor Beta 1 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7407D73E-2994-1337-E053-F662850A23A4","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCCF-4085-E063-731AD00A53CD","beginDate":"2020-04-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EGFR","valueDescription":"Epidermal Growth Factor Receptor Measurement","ValueMeaning":{"publicId":"6402900","version":"1","preferredName":"Epidermal Growth Factor Receptor Measurement","longName":"6402900","preferredDefinition":"The determination of the amount of epidermal growth factor receptor present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal Growth Factor Receptor Measurement","conceptCode":"C112273","definition":"The determination of the amount of epidermal growth factor receptor present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A70A2E-E503-1940-E053-F662850A868A","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD0-4085-E063-731AD00A53CD","beginDate":"2020-04-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"HGFR","valueDescription":"Hepatocyte Growth Factor Receptor Measurement","ValueMeaning":{"publicId":"7351856","version":"1","preferredName":"Hepatocyte Growth Factor Receptor Measurement","longName":"7351856","preferredDefinition":"The determination of the amount of hepatocyte growth factor receptor in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocyte Growth Factor Receptor Measurement","conceptCode":"C172514","definition":"The determination of the amount of hepatocyte growth factor receptor in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA679A32-1A34-32CD-E053-4EBD850A040F","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD2-4085-E063-731AD00A53CD","beginDate":"2020-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ICAM1","valueDescription":"Intercellular Adhesion Molecule 1 Measurement","ValueMeaning":{"publicId":"6404198","version":"1","preferredName":"Intercellular Adhesion Molecule 1 Measurement","longName":"6404198","preferredDefinition":"The determination of the amount of intercellular adhesion molecule 1 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intercellular Adhesion Molecule 1 Measurement","conceptCode":"C124345","definition":"The determination of the amount of intercellular adhesion molecule 1 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E0EE88-A2B3-71F0-E053-F662850A5B27","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD3-4085-E063-731AD00A53CD","beginDate":"2021-01-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LFA1","valueDescription":"Lymphocyte Function-Associated Antigen 1 Measurement","ValueMeaning":{"publicId":"7547079","version":"1","preferredName":"Lymphocyte Function-Associated Antigen 1 Measurement","longName":"7547079","preferredDefinition":"The determination of the amount of lymphocyte function-associated antigen 1 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphocyte Function-Associated Antigen 1 Measurement","conceptCode":"C176341","definition":"The determination of the amount of lymphocyte function-associated antigen 1 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7F0F-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD4-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TISABNUM","valueDescription":"Number of Abnormal Tissue Samples","ValueMeaning":{"publicId":"7547081","version":"1","preferredName":"Number of Abnormal Tissue Samples","longName":"7547081","preferredDefinition":"The total number of tissue samples in which a pathological abnormality has been observed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number of Abnormal Tissue Samples","conceptCode":"C176340","definition":"The total number of tissue samples in which a pathological abnormality has been observed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7F35-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD5-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PNTHCEMP","valueDescription":"Paneth Cell Metaplasia Assessment","ValueMeaning":{"publicId":"7547083","version":"1","preferredName":"Paneth Cell Metaplasia Assessment","longName":"7547083","preferredDefinition":"An evaluation of the presence or degree of paneth cell metaplasia in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paneth Cell Metaplasia Assessment","conceptCode":"C176339","definition":"An evaluation of the presence or degree of paneth cell metaplasia in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7F5B-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD6-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EPITHINT","valueDescription":"Epithelial Integrity Assessment","ValueMeaning":{"publicId":"7547085","version":"1","preferredName":"Epithelial Integrity Assessment","longName":"7547085","preferredDefinition":"An evaluation of the presence or degree of epithelial integrity in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial Integrity Assessment","conceptCode":"C176338","definition":"An evaluation of the presence or degree of epithelial integrity in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7F81-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD7-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CRYPARCD","valueDescription":"Crypt Architectural Damage Assessment","ValueMeaning":{"publicId":"7547087","version":"1","preferredName":"Crypt Architectural Damage Assessment","longName":"7547087","preferredDefinition":"An evaluation of the presence or degree of crypt architectural damage in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crypt Architectural Damage Assessment","conceptCode":"C176337","definition":"An evaluation of the presence or degree of crypt architectural damage in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7FA7-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD8-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CRYPABSC","valueDescription":"Crypt Abscess Assessment","ValueMeaning":{"publicId":"7547089","version":"1","preferredName":"Crypt Abscess Assessment","longName":"7547089","preferredDefinition":"An evaluation of the presence or degree of crypt abscess in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crypt Abscess Assessment","conceptCode":"C176336","definition":"An evaluation of the presence or degree of crypt abscess in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7FCD-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCD9-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CRYPTTS","valueDescription":"Cryptitis Assessment","ValueMeaning":{"publicId":"7547091","version":"1","preferredName":"Cryptitis Assessment","longName":"7547091","preferredDefinition":"An evaluation of the presence or degree of cryptitis in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryptitis Assessment","conceptCode":"C176335","definition":"An evaluation of the presence or degree of cryptitis in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-7FF3-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCDA-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GRNLMA","valueDescription":"Granuloma Assessment","ValueMeaning":{"publicId":"7547093","version":"1","preferredName":"Granuloma Assessment","longName":"7547093","preferredDefinition":"An evaluation of the presence or degree of granuloma in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granuloma Assessment","conceptCode":"C176334","definition":"An evaluation of the presence or degree of granuloma in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-8019-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCDB-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ULCER","valueDescription":"Ulceration Assessment","ValueMeaning":{"publicId":"7547095","version":"1","preferredName":"Ulceration Assessment","longName":"7547095","preferredDefinition":"An evaluation of the presence or degree of ulceration in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ulceration Assessment","conceptCode":"C176333","definition":"An evaluation of the presence or degree of ulceration in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B684D3-803F-7269-E053-4EBD850A6842","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-12","modifiedBy":"ONEDATA","dateModified":"2021-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCDC-4085-E063-731AD00A53CD","beginDate":"2021-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PYSACMSB","valueDescription":"Polysaccharides and Mucosubstances Measurement","ValueMeaning":{"publicId":"7627523","version":"1","preferredName":"Polysaccharides and Mucosubstances Measurement","longName":"7627523","preferredDefinition":"The determination of the amount of polysaccharides and mucosubstances in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polysaccharides and Mucosubstances Measurement","conceptCode":"C178047","definition":"The determination of the amount of polysaccharides and mucosubstances in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-5645-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCDD-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TUMRGR","valueDescription":"Tumor Regression Assessment","ValueMeaning":{"publicId":"7627525","version":"1","preferredName":"Tumor Regression Assessment","longName":"7627525","preferredDefinition":"An evaluation of the presence or degree of tumor regression present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Assessment","conceptCode":"C178046","definition":"An evaluation of the presence or degree of tumor regression present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-566B-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCDE-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EROULC","valueDescription":"Erosion and/or Ulceration Assessment","ValueMeaning":{"publicId":"7627527","version":"1","preferredName":"Erosion and/or Ulceration Assessment","longName":"7627527","preferredDefinition":"An evaluation of the presence or degree of erosion and/or ulceration present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erosion and/or Ulceration Assessment","conceptCode":"C178045","definition":"An evaluation of the presence or degree of erosion and/or ulceration present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-5691-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCDF-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NEUTEPI","valueDescription":"Neutrophils in Epithelium Assessment","ValueMeaning":{"publicId":"7627529","version":"1","preferredName":"Neutrophils in Epithelium Assessment","longName":"7627529","preferredDefinition":"An evaluation of the presence or degree of neutrophils in the epithelium present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutrophils in Epithelium Assessment","conceptCode":"C178044","definition":"An evaluation of the presence or degree of neutrophils in the epithelium present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-56B7-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE0-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NEUTLP","valueDescription":"Neutrophils in Lamina Propria Assessment","ValueMeaning":{"publicId":"7627531","version":"1","preferredName":"Neutrophils in Lamina Propria Assessment","longName":"7627531","preferredDefinition":"An evaluation of the presence or degree of neutrophils in the lamina propria present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutrophils in Lamina Propria Assessment","conceptCode":"C178043","definition":"An evaluation of the presence or degree of neutrophils in the lamina propria present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-56DD-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE1-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CHINFINL","valueDescription":"Chronic Inflammatory Infiltrate Assessment","ValueMeaning":{"publicId":"7627533","version":"1","preferredName":"Chronic Inflammatory Infiltrate Assessment","longName":"7627533","preferredDefinition":"An evaluation of the presence or degree of chronic inflammatory infiltrate present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Inflammatory Infiltrate Assessment","conceptCode":"C178042","definition":"An evaluation of the presence or degree of chronic inflammatory infiltrate present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-5703-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE2-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BIAFFNUM","valueDescription":"Number of Biopsy Specimens Affected","ValueMeaning":{"publicId":"7627535","version":"1","preferredName":"Number of Biopsy Specimens Affected","longName":"7627535","preferredDefinition":"The total number of biopsy specimens in which a finding has been observed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number of Biopsy Specimens Affected","conceptCode":"C178041","definition":"The total number of biopsy specimens in which a finding has been observed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-5729-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE3-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMNEPI","valueDescription":"Polymorphonuclear Cells in Epithelium Assessment","ValueMeaning":{"publicId":"7627537","version":"1","preferredName":"Polymorphonuclear Cells in Epithelium Assessment","longName":"7627537","preferredDefinition":"An evaluation of the presence or degree of polymorphonuclear cells in the epithelium present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymorphonuclear Cells in Epithelium Assessment","conceptCode":"C178040","definition":"An evaluation of the presence or degree of polymorphonuclear cells in the epithelium present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-574F-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE4-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMNINLLP","valueDescription":"Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment","ValueMeaning":{"publicId":"7627539","version":"1","preferredName":"Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment","longName":"7627539","preferredDefinition":"An evaluation of the presence or degree of infiltration of polymorphonuclear cells into the lamina propria present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment","conceptCode":"C178039","definition":"An evaluation of the presence or degree of infiltration of polymorphonuclear cells into the lamina propria present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-5775-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE5-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MNCINLLP","valueDescription":"Infiltration of Mononuclear Cells in Lamina Propria Assessment","ValueMeaning":{"publicId":"7627541","version":"1","preferredName":"Infiltration of Mononuclear Cells in Lamina Propria Assessment","longName":"7627541","preferredDefinition":"An evaluation of the presence or degree of infiltration of mononuclear cells into the lamina propria present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infiltration of Mononuclear Cells in Lamina Propria Assessment","conceptCode":"C178038","definition":"An evaluation of the presence or degree of infiltration of mononuclear cells into the lamina propria present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-579B-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE6-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ARCHCHG","valueDescription":"Architectural Changes Assessment","ValueMeaning":{"publicId":"7627543","version":"1","preferredName":"Architectural Changes Assessment","longName":"7627543","preferredDefinition":"An evaluation of the presence or degree of tissue architectural changes present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Architectural Changes Assessment","conceptCode":"C178037","definition":"An evaluation of the presence or degree of tissue architectural changes present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-57C1-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE7-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EPIDMG","valueDescription":"Epithelial Damage Assessment","ValueMeaning":{"publicId":"7627545","version":"1","preferredName":"Epithelial Damage Assessment","longName":"7627545","preferredDefinition":"An evaluation of the presence or degree of epithelial damage present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial Damage Assessment","conceptCode":"C178036","definition":"An evaluation of the presence or degree of epithelial damage present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-57E7-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE8-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LYEPIENT","valueDescription":"Intraepithelial Lymphocytes to Enterocytes Ratio Measurement","ValueMeaning":{"publicId":"7627547","version":"1","preferredName":"Intraepithelial Lymphocytes to Enterocytes Ratio Measurement","longName":"7627547","preferredDefinition":"A relative measurement (ratio or percentage) of the lymphocytes to enterocytes within the epithelium of a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraepithelial Lymphocytes to Enterocytes Ratio Measurement","conceptCode":"C178035","definition":"A relative measurement (ratio or percentage) of the lymphocytes to enterocytes within the epithelium of a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF7871F1-580D-4D39-E053-4EBD850ABCD8","latestVersionIndicator":"Yes","beginDate":"2021-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-04-08","modifiedBy":"ONEDATA","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCE9-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MNC","valueDescription":"Mononuclear Cell Count","ValueMeaning":{"publicId":"6619997","version":"1","preferredName":"Mononuclear Cell Count","longName":"6619997","preferredDefinition":"The determination of the amount of mononuclear cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mononuclear Cell Count","conceptCode":"C154757","definition":"The determination of the amount of mononuclear cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"809B3770-0D05-3F38-E053-F662850ACD1F","latestVersionIndicator":"Yes","beginDate":"2019-01-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-01-29","modifiedBy":"ONEDATA","dateModified":"2019-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCEA-4085-E063-731AD00A53CD","beginDate":"2021-04-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ARV7","valueDescription":"Androgen Receptor Variant 7 Measurement","ValueMeaning":{"publicId":"8002764","version":"1","preferredName":"Androgen Receptor Variant 7 Measurement","longName":"8002764","preferredDefinition":"The determination of the amount of androgen receptor variant 7 protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Androgen Receptor Variant 7 Measurement","conceptCode":"C184703","definition":"The determination of the amount of androgen receptor variant 7 protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D564FDE2-0B8B-18F7-E053-4EBD850A2ADD","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCEB-4085-E063-731AD00A53CD","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LNEXCPSD","valueDescription":"Lymph Node Extracapsular Spread Assessment","ValueMeaning":{"publicId":"8002766","version":"1","preferredName":"Lymph Node Extracapsular Spread Assessment","longName":"8002766","preferredDefinition":"An evaluation of the presence or degree of lymph node extracapsular spread present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node Extracapsular Spread Assessment","conceptCode":"C184702","definition":"An evaluation of the presence or degree of lymph node extracapsular spread present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D564FDE2-0BB1-18F7-E053-4EBD850A2ADD","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCEC-4085-E063-731AD00A53CD","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMLIGCEM","valueDescription":"Premalignant Cell Morphology Assessment","ValueMeaning":{"publicId":"8002768","version":"1","preferredName":"Premalignant Cell Morphology Assessment","longName":"8002768","preferredDefinition":"An examination or assessment of the form and structure of premalignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Premalignant Cell Morphology Assessment","conceptCode":"C184701","definition":"An examination or assessment of the form and structure of premalignant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D564FDE2-0BD7-18F7-E053-4EBD850A2ADD","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCED-4085-E063-731AD00A53CD","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMLIGCE","valueDescription":"Premalignant Cell Count","ValueMeaning":{"publicId":"8002770","version":"1","preferredName":"Premalignant Cell Count","longName":"8002770","preferredDefinition":"The determination of the amount of premalignant cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Premalignant Cell Count","conceptCode":"C184700","definition":"The determination of the amount of premalignant cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D564FDE2-0BFD-18F7-E053-4EBD850A2ADD","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCEE-4085-E063-731AD00A53CD","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EMVI","valueDescription":"Extramural Venous Invasion Assessment","ValueMeaning":{"publicId":"8002772","version":"1","preferredName":"Extramural Venous Invasion Assessment","longName":"8002772","preferredDefinition":"An evaluation of the presence or degree of extramural venous invasion present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extramural Venous Invasion Assessment","conceptCode":"C184699","definition":"An evaluation of the presence or degree of extramural venous invasion present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D564FDE2-0C23-18F7-E053-4EBD850A2ADD","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCEF-4085-E063-731AD00A53CD","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SGMGIREG","valueDescription":"Anatomic Site for Involved Surgical Margin","ValueMeaning":{"publicId":"8002774","version":"1","preferredName":"Anatomic Site for Involved Surgical Margin","longName":"8002774","preferredDefinition":"The anatomic site where there is one or more surgical margins where diseased tissue is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anatomic Site for Involved Surgical Margin","conceptCode":"C177569","definition":"The anatomic site where there is one or more surgical margins where diseased tissue is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D564FDE2-0C49-18F7-E053-4EBD850A2ADD","latestVersionIndicator":"Yes","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-01-12","modifiedBy":"ONEDATA","dateModified":"2022-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF0-4085-E063-731AD00A53CD","beginDate":"2022-01-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"P16INK4A","valueDescription":"p16-INK4A Measurement","ValueMeaning":{"publicId":"7741391","version":"1","preferredName":"p16-INK4A Measurement","longName":"7741391","preferredDefinition":"The determination of the amount of p16-INK4A present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"p16-INK4A Measurement","conceptCode":"C179766","definition":"The determination of the amount of p16-INK4A present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C72D2642-572F-48B5-E053-4EBD850AB102","latestVersionIndicator":"Yes","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-15","modifiedBy":"ONEDATA","dateModified":"2021-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF1-4085-E063-731AD00A53CD","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LNSTATE","valueDescription":"Lymph Node State","ValueMeaning":{"publicId":"6658378","version":"1","preferredName":"Lymph Node State","longName":"6658378","preferredDefinition":"A condition or state of a lymph node at a particular time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node State","conceptCode":"C124448","definition":"A condition or state of a lymph node at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"826F49EA-EEC2-6216-E053-F662850AFAC0","latestVersionIndicator":"Yes","beginDate":"2019-02-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-02-21","modifiedBy":"ONEDATA","dateModified":"2019-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF2-4085-E063-731AD00A53CD","beginDate":"2021-07-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"STSEXT","valueDescription":"Steatosis Extent","ValueMeaning":{"publicId":"7798034","version":"1","preferredName":"Steatosis Extent","longName":"7798034","preferredDefinition":"An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Steatosis Extent","conceptCode":"C181477","definition":"An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-01DE-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF3-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"OVLTGRD","valueDescription":"Histologic Grade","ValueMeaning":{"publicId":"2676380","version":"1","preferredName":"Histologic Grade","longName":"2676380","preferredDefinition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39063D88-FB8A-2625-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-31","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-08-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF4-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"DIAGNOS","valueDescription":"Diagnosis","ValueMeaning":{"publicId":"4434771","version":"1","preferredName":"Diagnosis","longName":"4434771v1.00","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FFD61BEB-3E61-9144-E040-BB89AD43512E","latestVersionIndicator":"Yes","beginDate":"2014-08-04","endDate":null,"createdBy":"WONGW","dateCreated":"2014-08-04","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/2022: accidentally changed this VM then changed back to what it was.wz","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF5-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MITOSCR","valueDescription":"Mitotic Rate Score","ValueMeaning":{"publicId":"7798035","version":"1","preferredName":"Mitotic Rate Score","longName":"7798035","preferredDefinition":"A score assigned to a biopsy sample to indicate the number of mitotic cells present in a tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Rate Score","conceptCode":"C138982","definition":"A score assigned to a biopsy sample to indicate the number of mitotic cells present in a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0222-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF6-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CYEXAM","valueDescription":"Cytogenetic Analysis","ValueMeaning":{"publicId":"2861225","version":"1","preferredName":"Cytogenetic Analysis","longName":"2861225","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"679D66C6-4660-310F-E040-BB89AD4302D9","latestVersionIndicator":"Yes","beginDate":"2009-04-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF7-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NT5E","valueDescription":"Ecto-5'-Nucleotidase Measurement","ValueMeaning":{"publicId":"7798037","version":"1","preferredName":"Ecto-5'-Nucleotidase Measurement","longName":"7798037","preferredDefinition":"The determination of the amount of ecto-5'-nucleotidase in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ecto-5'-Nucleotidase Measurement","conceptCode":"C181656","definition":"The determination of the amount of ecto-5'-nucleotidase in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-025F-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF8-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"APOCE","valueDescription":"Apoptotic Cell Count","ValueMeaning":{"publicId":"7798039","version":"1","preferredName":"Apoptotic Cell Count","longName":"7798039","preferredDefinition":"The determination of the amount of apoptotic cells in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apoptotic Cell Count","conceptCode":"C181495","definition":"The determination of the amount of apoptotic cells in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0285-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCF9-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"APOCECE","valueDescription":"Apoptotic Cell to Total Cell Count","ValueMeaning":{"publicId":"7798041","version":"1","preferredName":"Apoptotic Cell to Total Cell Count","longName":"7798041","preferredDefinition":"The determination of the ratio of apoptotic cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apoptotic Cell to Total Cell Count","conceptCode":"C181494","definition":"The determination of the ratio of apoptotic cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-02AB-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCFA-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LNININD","valueDescription":"Lymph Node Involvement Indicator","ValueMeaning":{"publicId":"7798043","version":"1","preferredName":"Lymph Node Involvement Indicator","longName":"7798043","preferredDefinition":"An indication as to whether cancer is present in the lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node Involvement Indicator","conceptCode":"C181493","definition":"An indication as to whether cancer is present in the lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-02D1-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCFB-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NCRPLEOM","valueDescription":"Nuclear Pleomorphism Assessment","ValueMeaning":{"publicId":"7798045","version":"1","preferredName":"Nuclear Pleomorphism Assessment","longName":"7798045","preferredDefinition":"An evaluation of the presence or degree of nuclear pleomorphism in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear Pleomorphism Assessment","conceptCode":"C181492","definition":"An evaluation of the presence or degree of nuclear pleomorphism in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-02F7-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCFC-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TBLFRM","valueDescription":"Tubule Formation Assessment","ValueMeaning":{"publicId":"7798047","version":"1","preferredName":"Tubule Formation Assessment","longName":"7798047","preferredDefinition":"An evaluation of the presence or degree of tubule formation in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubule Formation Assessment","conceptCode":"C181491","definition":"An evaluation of the presence or degree of tubule formation in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-031D-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCFD-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"IEPINEOA","valueDescription":"Intraepithelial Neoplasia Assessment","ValueMeaning":{"publicId":"7798049","version":"1","preferredName":"Intraepithelial Neoplasia Assessment","longName":"7798049","preferredDefinition":"An evaluation of the presence or degree of intraepithelial neoplasia in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraepithelial Neoplasia Assessment","conceptCode":"C181490","definition":"An evaluation of the presence or degree of intraepithelial neoplasia in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0343-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCFE-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NUCLGLCG","valueDescription":"Glycogenated Nuclei Assessment","ValueMeaning":{"publicId":"7798051","version":"1","preferredName":"Glycogenated Nuclei Assessment","longName":"7798051","preferredDefinition":"An evaluation of the presence or degree of glycogenated nuclei in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycogenated Nuclei Assessment","conceptCode":"C181489","definition":"An evaluation of the presence or degree of glycogenated nuclei in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0369-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FCFF-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MALLBOD","valueDescription":"Mallory Body Assessment","ValueMeaning":{"publicId":"7798053","version":"1","preferredName":"Mallory Body Assessment","longName":"7798053","preferredDefinition":"An evaluation of the presence or degree of mallory bodies in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mallory Body Assessment","conceptCode":"C181488","definition":"An evaluation of the presence or degree of mallory bodies in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-038F-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD00-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MEGAMITC","valueDescription":"Megamitochondria Assessment","ValueMeaning":{"publicId":"7798055","version":"1","preferredName":"Megamitochondria Assessment","longName":"7798055","preferredDefinition":"An evaluation of the presence or degree of megamitochondria in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Megamitochondria Assessment","conceptCode":"C181487","definition":"An evaluation of the presence or degree of megamitochondria in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-03B5-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD01-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MPHGPIG","valueDescription":"Pigmented Macrophage Assessment","ValueMeaning":{"publicId":"7798057","version":"1","preferredName":"Pigmented Macrophage Assessment","longName":"7798057","preferredDefinition":"An evaluation of the presence or degree of pigmented macrophages in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pigmented Macrophage Assessment","conceptCode":"C181486","definition":"An evaluation of the presence or degree of pigmented macrophages in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-03DB-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD02-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ACDOBOD","valueDescription":"Acidophil Body Assessment","ValueMeaning":{"publicId":"7798059","version":"1","preferredName":"Acidophil Body Assessment","longName":"7798059","preferredDefinition":"An evaluation of the presence or degree of acidophil body in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acidophil Body Assessment","conceptCode":"C181485","definition":"An evaluation of the presence or degree of acidophil body in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0401-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD03-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"HEPBLLN","valueDescription":"Hepatocellular Ballooning Assessment","ValueMeaning":{"publicId":"7798020","version":"1","preferredName":"Hepatocellular Ballooning Assessment","longName":"7798020","preferredDefinition":"An evaluation of the presence or degree of hepatocellular ballooning in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Ballooning Assessment","conceptCode":"C181484","definition":"An evaluation of the presence or degree of hepatocellular ballooning in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-00D4-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD04-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PORTINF","valueDescription":"Portal Inflammation Assessment","ValueMeaning":{"publicId":"7798022","version":"1","preferredName":"Portal Inflammation Assessment","longName":"7798022","preferredDefinition":"An evaluation of the presence or degree of portal inflammation in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Portal Inflammation Assessment","conceptCode":"C181483","definition":"An evaluation of the presence or degree of portal inflammation in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-00FA-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD05-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LPGNLMLG","valueDescription":"Large Lipogranuloma Assessment","ValueMeaning":{"publicId":"7798024","version":"1","preferredName":"Large Lipogranuloma Assessment","longName":"7798024","preferredDefinition":"An evaluation of the presence or degree of large lipogranuloma in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Lipogranuloma Assessment","conceptCode":"C181482","definition":"An evaluation of the presence or degree of large lipogranuloma in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0120-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD06-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MCGNLM","valueDescription":"Microgranuloma Assessment","ValueMeaning":{"publicId":"7798026","version":"1","preferredName":"Microgranuloma Assessment","longName":"7798026","preferredDefinition":"An evaluation of the presence or degree of microgranuloma in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microgranuloma Assessment","conceptCode":"C181481","definition":"An evaluation of the presence or degree of microgranuloma in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0146-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD07-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LOBLINF","valueDescription":"Lobular Inflammation Assessment","ValueMeaning":{"publicId":"7798028","version":"1","preferredName":"Lobular Inflammation Assessment","longName":"7798028","preferredDefinition":"An evaluation of the presence or degree of lobular inflammation in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lobular Inflammation Assessment","conceptCode":"C181480","definition":"An evaluation of the presence or degree of lobular inflammation in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-016C-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD08-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MVSTS","valueDescription":"Microvesicular Steatosis Assessment","ValueMeaning":{"publicId":"7798030","version":"1","preferredName":"Microvesicular Steatosis Assessment","longName":"7798030","preferredDefinition":"An evaluation of the presence or degree of crypt architectural damage in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microvesicular Steatosis Assessment","conceptCode":"C181479","definition":"An evaluation of the presence or degree of crypt architectural damage in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-0192-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD09-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"STSLOC","valueDescription":"Steatosis Location","ValueMeaning":{"publicId":"7798032","version":"1","preferredName":"Steatosis Location","longName":"7798032","preferredDefinition":"An evaluation of the predominant distribution pattern of steatosis (fatty tissue) in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Steatosis Location","conceptCode":"C181478","definition":"An evaluation of the predominant distribution pattern of steatosis (fatty tissue) in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4FA645-01B8-5E75-E053-4EBD850AA65F","latestVersionIndicator":"Yes","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-14","modifiedBy":"ONEDATA","dateModified":"2021-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD0A-4085-E063-731AD00A53CD","beginDate":"2021-10-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TRCETMCE","valueDescription":"Transitional Cell to Tumor Cell Ratio Measurement","ValueMeaning":{"publicId":"6618631","version":"1","preferredName":"Transitional Cell to Tumor Cell Ratio Measurement","longName":"6618631","preferredDefinition":"The determination of the ratio of transitional cells compared to tumor cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transitional Cell to Tumor Cell Ratio Measurement","conceptCode":"C154800","definition":"The determination of the ratio of transitional cells compared to tumor cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-48E6-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD0B-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NEOCE","valueDescription":"Tumor Cell Count","ValueMeaning":{"publicId":"6618633","version":"1","preferredName":"Neoplastic Cells","longName":"6618633v1.00","preferredDefinition":"The determination of the amount of tumor cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Cell Count","conceptCode":"C154801","definition":"The determination of the amount of tumor cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-490C-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"KUMMEROA","dateModified":"2022-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD0C-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SMUSCAB","valueDescription":"Smooth Muscle Antibody Measurement","ValueMeaning":{"publicId":"6407687","version":"1","preferredName":"Smooth Muscle Antibody Measurement","longName":"6407687","preferredDefinition":"The determination of the amount of smooth muscle antibody present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Smooth Muscle Antibody Measurement","conceptCode":"C111317","definition":"The determination of the amount of smooth muscle antibody present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3DCAA-5136-2714-E053-F662850A304C","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-21","modifiedBy":"ONEDATA_WA","dateModified":"2024-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD0D-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ROS1","valueDescription":"ROS1 Protein Measurement","ValueMeaning":{"publicId":"6618635","version":"1","preferredName":"ROS1 Protein Measurement","longName":"6618635","preferredDefinition":"The determination of the amount of ROS1 protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ROS1 Protein Measurement","conceptCode":"C154804","definition":"The determination of the amount of ROS1 protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-4947-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD0E-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PDL1","valueDescription":"Programmed Death Ligand 1 Measurement","ValueMeaning":{"publicId":"6618639","version":"1","preferredName":"Programmed Death Ligand 1 Measurement","longName":"6618639","preferredDefinition":"The determination of the amount of PD-L1 protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Programmed Death Ligand 1 Measurement","conceptCode":"C154807","definition":"The determination of the amount of PD-L1 protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-4993-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD0F-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MYFIBROS","valueDescription":"Myelofibrosis Assessment","ValueMeaning":{"publicId":"6618641","version":"1","preferredName":"Myelofibrosis Assessment","longName":"6618641","preferredDefinition":"An evaluation of myelofibrosis in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelofibrosis Assessment","conceptCode":"C154803","definition":"An evaluation of myelofibrosis in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-49B9-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD10-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"HISTTYPC","valueDescription":"Histologic Type of Cancer","ValueMeaning":{"publicId":"6618643","version":"1","preferredName":"Histologic Type of Cancer","longName":"6618643","preferredDefinition":"The determination of the histologic type of cancer in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type of Cancer","conceptCode":"C154802","definition":"The determination of the histologic type of cancer in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-49DF-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD11-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ERLIERLT","valueDescription":"Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement","ValueMeaning":{"publicId":"6618645","version":"1","preferredName":"Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement","longName":"6618645","preferredDefinition":"The determination of the ratio of intact epithelial reticular basement membrane length compared to total epithelial reticular basement membrane length present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement","conceptCode":"C156547","definition":"The determination of the ratio of intact epithelial reticular basement membrane length compared to total epithelial reticular basement membrane length present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803AE359-4A05-1532-E053-F662850AD245","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD12-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NKX2_1","valueDescription":"NK2 Homeobox 1 Measurement","ValueMeaning":{"publicId":"6422590","version":"1","preferredName":"NK2 Homeobox 1 Measurement","longName":"6422590","preferredDefinition":"The determination of the amount of the NKX2.1 transcription factor present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NK2 Homeobox 1 Measurement","conceptCode":"C123558","definition":"The determination of the amount of the NKX2.1 transcription factor present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EC0F-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD13-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NORMCECE","valueDescription":"Normal Cell to Total Cell Ratio Measurement","ValueMeaning":{"publicId":"6422588","version":"1","preferredName":"Normal Cell to Total Cell Ratio Measurement","longName":"6422588","preferredDefinition":"The determination of the ratio of normal cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal Cell to Total Cell Ratio Measurement","conceptCode":"C127767","definition":"The determination of the ratio of normal cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EBE9-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD14-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CORBIOMN","valueDescription":"Number of Malignant Biopsy Cores","ValueMeaning":{"publicId":"6422586","version":"1","preferredName":"Number of Malignant Biopsy Cores","longName":"6422586","preferredDefinition":"A measurement of the total number of core biopsies that contain malignant tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number of Malignant Biopsy Cores","conceptCode":"C139092","definition":"A measurement of the total number of core biopsies that contain malignant tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EBC3-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD15-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PAX3FKHR","valueDescription":"PAX3-FKHR Fusion Protein Measurement","ValueMeaning":{"publicId":"6422584","version":"1","preferredName":"PAX3-FKHR Fusion Protein Measurement","longName":"6422584","preferredDefinition":"The determination of the amount of PAX3-FKHR fusion protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PAX3-FKHR Fusion Protein Measurement","conceptCode":"C142348","definition":"The determination of the amount of PAX3-FKHR fusion protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EB9D-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD16-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PCTISCA","valueDescription":"Percentage of in situ Carcinoma","ValueMeaning":{"publicId":"6422582","version":"1","preferredName":"Percentage of in situ Carcinoma","longName":"6422582","preferredDefinition":"A relative measurement (percentage) of in situ component present in a carcinoma compared to the entire malignant cellular proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage of in situ Carcinoma","conceptCode":"C123559","definition":"A relative measurement (percentage) of in situ component present in a carcinoma compared to the entire malignant cellular proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EB77-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD17-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PNLINV","valueDescription":"Perineural Invasion Assessment","ValueMeaning":{"publicId":"6422580","version":"1","preferredName":"Perineural Invasion Assessment","longName":"6422580","preferredDefinition":"An evaluation of the presence or degree of perineural invasion present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perineural Invasion Assessment","conceptCode":"C127768","definition":"An evaluation of the presence or degree of perineural invasion present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EB51-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD18-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PTBCPLTS","valueDescription":"Peritubular Capillaritis Assessment","ValueMeaning":{"publicId":"6422578","version":"1","preferredName":"Peritubular Capillaritis Assessment","longName":"6422578","preferredDefinition":"An evaluation of the presence or degree of peritubular capillaritis present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritubular Capillaritis Assessment","conceptCode":"C135473","definition":"An evaluation of the presence or degree of peritubular capillaritis present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EB2B-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD19-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PTEN","valueDescription":"Phosphatase and Tensin Homolog Measurement","ValueMeaning":{"publicId":"6422576","version":"1","preferredName":"Phosphatase and Tensin Homolog Measurement","longName":"6422576","preferredDefinition":"The determination of the amount of phosphatase and tensin homolog protein in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phosphatase and Tensin Homolog Measurement","conceptCode":"C147470","definition":"The determination of the amount of phosphatase and tensin homolog protein in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EB05-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD1A-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PECAM1","valueDescription":"Platelet Endothelial Cell Adhesion Molecule 1 Measurement","ValueMeaning":{"publicId":"6422574","version":"1","preferredName":"Platelet Endothelial Cell Adhesion Molecule 1 Measurement","longName":"6422574","preferredDefinition":"The determination of the amount of platelet endothelial cell adhesion molecule 1 in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet Endothelial Cell Adhesion Molecule 1 Measurement","conceptCode":"C135472","definition":"The determination of the amount of platelet endothelial cell adhesion molecule 1 in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EADF-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD1B-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMS2","valueDescription":"PMS1 Homolog 2 Measurement","ValueMeaning":{"publicId":"6422572","version":"1","preferredName":"PMS1 Homolog 2 Measurement","longName":"6422572","preferredDefinition":"The determination of the amount of PMS1 homolog 2 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PMS1 Homolog 2 Measurement","conceptCode":"C139097","definition":"The determination of the amount of PMS1 homolog 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EAB9-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD1C-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PROGESTR","valueDescription":"Progesterone Receptor Measurement","ValueMeaning":{"publicId":"6401947","version":"1","preferredName":"Progesterone Receptor Measurement","longName":"6401947","preferredDefinition":"The determination of the amount of progesterone receptor present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor Measurement","conceptCode":"C117846","definition":"The determination of the amount of progesterone receptor present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7394E67C-50AD-136A-E053-F662850A3EC6","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD1D-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PAP","valueDescription":"Prostatic Acid Phosphatase Measurement","ValueMeaning":{"publicId":"6402495","version":"1","preferredName":"Prostatic Acid Phosphatase Measurement","longName":"6402495","preferredDefinition":"The determination of the amount of prostatic acid phosphatase present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostatic Acid Phosphatase Measurement","conceptCode":"C80204","definition":"The determination of the amount of prostatic acid phosphatase present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A574CE-43A6-2E46-E053-F662850A1E40","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD1E-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"S100A7","valueDescription":"S100 Calcium Binding Protein A7 Measurement","ValueMeaning":{"publicId":"6422570","version":"1","preferredName":"S100 Calcium Binding Protein A7 Measurement","longName":"6422570","preferredDefinition":"The determination of the amount of S100 calcium binding protein A7 protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S100 Calcium Binding Protein A7 Measurement","conceptCode":"C127769","definition":"The determination of the amount of S100 calcium binding protein A7 protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EA7D-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD1F-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"STRMCECE","valueDescription":"Stromal Cell to Total Cell Ratio Measurement","ValueMeaning":{"publicId":"6422568","version":"1","preferredName":"Stromal Cell to Total Cell Ratio Measurement","longName":"6422568","preferredDefinition":"The determination of the ratio of stromal cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stromal Cell to Total Cell Ratio Measurement","conceptCode":"C127770","definition":"The determination of the ratio of stromal cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EA57-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD20-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SGMGSTAT","valueDescription":"Surgical Margins Status","ValueMeaning":{"publicId":"6422566","version":"1","preferredName":"Surgical Margins Status","longName":"6422566","preferredDefinition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Margins Status","conceptCode":"C123560","definition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EA31-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD21-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"THICK","valueDescription":"Thickness","ValueMeaning":{"publicId":"4493983","version":"1","preferredName":"Thickness","longName":"4493983","preferredDefinition":"The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length: also, viscous consistency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thickness","conceptCode":"C41145","definition":"The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length: also, viscous consistency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0439C873-29F8-F68E-E050-BB89AD43799F","latestVersionIndicator":"Yes","beginDate":"2014-09-29","endDate":null,"createdBy":"RODGERSC","dateCreated":"2014-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD22-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TUBATRO","valueDescription":"Tubular Atrophy Assessment","ValueMeaning":{"publicId":"6422564","version":"1","preferredName":"Tubular Atrophy Assessment","longName":"6422564","preferredDefinition":"An evaluation of the presence or degree of tubular atrophy present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubular Atrophy Assessment","conceptCode":"C135474","definition":"An evaluation of the presence or degree of tubular atrophy present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-EA01-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD23-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TUBULTIS","valueDescription":"Tubulitis Assessment","ValueMeaning":{"publicId":"6422562","version":"1","preferredName":"Tubulitis Assessment","longName":"6422562","preferredDefinition":"An evaluation of the presence or degree of tubulitis present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubulitis Assessment","conceptCode":"C135475","definition":"An evaluation of the presence or degree of tubulitis present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-E9DB-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD24-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"VFBINTMT","valueDescription":"Vascular Fibrous Intimal Thickening Assessment","ValueMeaning":{"publicId":"6422558","version":"1","preferredName":"Vascular Fibrous Intimal Thickening Assessment","longName":"6422558","preferredDefinition":"An evaluation of the presence or degree of vascular fibrous intimal thickening present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular Fibrous Intimal Thickening Assessment","conceptCode":"C135476","definition":"An evaluation of the presence or degree of vascular fibrous intimal thickening present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-E98F-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD25-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"VASINV","valueDescription":"Vascular Invasion Assessment","ValueMeaning":{"publicId":"6422556","version":"1","preferredName":"Vascular Invasion Assessment","longName":"6422556","preferredDefinition":"An evaluation of the presence or degree of vascular invasion present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular Invasion Assessment","conceptCode":"C127772","definition":"An evaluation of the presence or degree of vascular invasion present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74947F3A-E969-6483-E053-F662850AF466","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD26-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EGFRVP","valueDescription":"EGFR Variant Protein Measurement","ValueMeaning":{"publicId":"6618621","version":"1","preferredName":"EGFR Variant Protein Measurement","longName":"6618621","preferredDefinition":"The determination of the amount of EGFR variant protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Variant Protein Measurement","conceptCode":"C154806","definition":"The determination of the amount of EGFR variant protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803BED72-AB99-74F6-E053-F662850A6CF9","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD27-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BLDVESD","valueDescription":"Blood Vessel Density","ValueMeaning":{"publicId":"6618625","version":"1","preferredName":"Blood Vessel Density","longName":"6618625","preferredDefinition":"An evaluation of the degree of blood vessel density present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Vessel Density","conceptCode":"C156545","definition":"An evaluation of the degree of blood vessel density present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803BED72-AC06-74F6-E053-F662850A6CF9","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD2C-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BD1","valueDescription":"Beta-defensin 1 Measurement","ValueMeaning":{"publicId":"6618627","version":"1","preferredName":"Beta-defensin 1 Measurement","longName":"6618627","preferredDefinition":"The determination of the amount of beta-defensin 1 in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beta-defensin 1 Measurement","conceptCode":"C156546","definition":"The determination of the amount of beta-defensin 1 in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803BED72-AC2C-74F6-E053-F662850A6CF9","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD2D-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ALK","valueDescription":"ALK Protein Measurement","ValueMeaning":{"publicId":"6618629","version":"1","preferredName":"ALK Protein Measurement","longName":"6618629","preferredDefinition":"The determination of the amount of ALK protein present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Protein Measurement","conceptCode":"C154805","definition":"The determination of the amount of ALK protein present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803BED72-AC52-74F6-E053-F662850A6CF9","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD2E-4085-E063-731AD00A53CD","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ABNCE","valueDescription":"Abnormal Cell Count","ValueMeaning":{"publicId":"6402861","version":"1","preferredName":"Abnormal Cell Count","longName":"6402861","preferredDefinition":"The determination of the amount of abnormal cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal Cell Count","conceptCode":"C111124","definition":"The determination of the amount of abnormal cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A6F003-7342-3653-E053-F662850AA5BB","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD2F-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"AMACR","valueDescription":"Alpha-Methylacyl Coenzyme A Racemase Measurement","ValueMeaning":{"publicId":"6402769","version":"1","preferredName":"Alpha-Methylacyl Coenzyme A Racemase Measurement","longName":"6402769","preferredDefinition":"The determination of the amount of alpha-methylacyl coenzyme A racemase in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-Methylacyl Coenzyme A Racemase Measurement","conceptCode":"C132364","definition":"The determination of the amount of alpha-methylacyl coenzyme A racemase in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A787F0-1DA8-1F34-E053-F662850AE73C","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD30-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ARTLRHYT","valueDescription":"Arteriolar Hyaline Thickening Assessment","ValueMeaning":{"publicId":"6422522","version":"1","preferredName":"Arteriolar Hyaline Thickening Assessment","longName":"6422522","preferredDefinition":"An evaluation of the presence or degree of arteriolar hyaline thickening present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arteriolar Hyaline Thickening Assessment","conceptCode":"C135463","definition":"An evaluation of the presence or degree of arteriolar hyaline thickening present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1BA0-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD31-4085-E063-731AD00A53CD","beginDate":"2018-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMS1","valueDescription":"PMS1 Homolog 1 Measurement","ValueMeaning":{"publicId":"8166874","version":"1","preferredName":"PMS1 Homolog 1 Measurement","longName":"8166874","preferredDefinition":"The determination of the amount of PMS1 mismatch repair protein in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PMS1 Homolog 1 Measurement","conceptCode":"C186206","definition":"The determination of the amount of PMS1 mismatch repair protein in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC8D81C6-B37E-7954-E053-4EBD850A6971","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD32-4085-E063-731AD00A53CD","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"P53","valueDescription":"Cellular Tumor Antigen p53 Measurement","ValueMeaning":{"publicId":"8166876","version":"1","preferredName":"Cellular Tumor Antigen p53 Measurement","longName":"8166876","preferredDefinition":"The determination of the amount of tumor protein p53 in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Tumor Antigen p53 Measurement","conceptCode":"C186205","definition":"The determination of the amount of tumor protein p53 in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC8D81C6-B3A4-7954-E053-4EBD850A6971","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD33-4085-E063-731AD00A53CD","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MSH3","valueDescription":"MutS Homolog 3 Measurement","ValueMeaning":{"publicId":"8166878","version":"1","preferredName":"MutS Homolog 3 Measurement","longName":"8166878","preferredDefinition":"The determination of the amount of MSH3 mismatch repair protein in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MutS Homolog 3 Measurement","conceptCode":"C186204","definition":"The determination of the amount of MSH3 mismatch repair protein in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC8D81C6-B3CA-7954-E053-4EBD850A6971","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD34-4085-E063-731AD00A53CD","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MLH3","valueDescription":"MutL Homolog 3 Measurement","ValueMeaning":{"publicId":"8166880","version":"1","preferredName":"MutL Homolog 3 Measurement","longName":"8166880","preferredDefinition":"The determination of the amount of MLH3 mismatch repair protein in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MutL Homolog 3 Measurement","conceptCode":"C186203","definition":"The determination of the amount of MLH3 mismatch repair protein in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC8D81C6-B3F0-7954-E053-4EBD850A6971","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD35-4085-E063-731AD00A53CD","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MMRPROT","valueDescription":"Mismatch Repair Protein Measurement","ValueMeaning":{"publicId":"8166882","version":"1","preferredName":"Mismatch Repair Protein Measurement","longName":"8166882","preferredDefinition":"An evaluation of the mismatch repair proteins in a biological sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair Protein Measurement","conceptCode":"C185932","definition":"An evaluation of the mismatch repair proteins in a biological sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC8D81C6-B416-7954-E053-4EBD850A6971","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD36-4085-E063-731AD00A53CD","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NEOCECE","valueDescription":"Cancer Cellularity Measurement","ValueMeaning":{"publicId":"6422514","version":"1","preferredName":"Cancer Cellularity Measurement","longName":"6422514","preferredDefinition":"The determination of the ratio of neoplastic cells compared to total cells in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Cellularity Measurement","conceptCode":"C123556","definition":"The determination of the ratio of neoplastic cells compared to total cells in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7494170D-1AFD-1C93-E053-F662850A09CC","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-29","modifiedBy":"ONEDATA","dateModified":"2018-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD37-4085-E063-731AD00A53CD","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"ONEDATA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LYMCE","valueDescription":null,"ValueMeaning":{"publicId":"6407267","version":"1","preferredName":"Lymphocyte to Total Cell Ratio Measurement","longName":"6407267","preferredDefinition":"The determination of the ratio of lymphocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphocyte to Total Cell Ratio Measurement","conceptCode":"C98751","definition":"The determination of the ratio of lymphocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F364F1-6C8F-025B-E053-F662850AF0BE","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD38-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BLSTMKCE","valueDescription":null,"ValueMeaning":{"publicId":"6409751","version":"1","preferredName":"Megakaryoblast to Total Cell Ratio Measurement","longName":"6409751","preferredDefinition":"The determination of the ratio of megakaryoblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Megakaryoblast to Total Cell Ratio Measurement","conceptCode":"C98753","definition":"The determination of the ratio of megakaryoblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741CD07C-CF8E-5D04-E053-F662850AB15B","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD39-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"METAMYCE","valueDescription":null,"ValueMeaning":{"publicId":"6409753","version":"1","preferredName":"Metamyelocyte to Total Cell Ratio Measurement","longName":"6409753","preferredDefinition":"The determination of the ratio of metamyelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metamyelocyte to Total Cell Ratio Measurement","conceptCode":"C98754","definition":"The determination of the ratio of metamyelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741CD07C-CFB4-5D04-E053-F662850AB15B","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD3A-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BLSTMBCE","valueDescription":null,"ValueMeaning":{"publicId":"6409755","version":"1","preferredName":"Myeloblast to Total Cell Ratio Measurement","longName":"6409755","preferredDefinition":"The determination of the ratio of myeloblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloblast to Total Cell Ratio Measurement","conceptCode":"C98761","definition":"The determination of the ratio of myeloblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741CD07C-CFDA-5D04-E053-F662850AB15B","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD3B-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PROMYCE","valueDescription":null,"ValueMeaning":{"publicId":"6409757","version":"1","preferredName":"Promyelocyte to Total Cell Ratio Measurement","longName":"6409757","preferredDefinition":"The determination of the ratio of promyelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Promyelocyte to Total Cell Ratio Measurement","conceptCode":"C98773","definition":"The determination of the ratio of promyelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741CD07C-D000-5D04-E053-F662850AB15B","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD3C-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BASOCE","valueDescription":null,"ValueMeaning":{"publicId":"6407523","version":"1","preferredName":"Basophil to Total Cell Ratio Measurement","longName":"6407523","preferredDefinition":"The determination of the ratio of basophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basophil to Total Cell Ratio Measurement","conceptCode":"C98865","definition":"The determination of the ratio of basophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F40357-6961-27BB-E053-F662850A157A","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD3D-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MYCYCE","valueDescription":null,"ValueMeaning":{"publicId":"6409714","version":"1","preferredName":"Myelocyte to Total Cell Ratio Measurement","longName":"6409714","preferredDefinition":"The determination of the ratio of myelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelocyte to Total Cell Ratio Measurement","conceptCode":"C98868","definition":"The determination of the ratio of myelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741BE03F-C8B6-64C4-E053-F662850AB651","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD3E-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PLSTCECE","valueDescription":null,"ValueMeaning":{"publicId":"6409716","version":"1","preferredName":"Plasma Cell to Total Cell Ratio Measurement","longName":"6409716","preferredDefinition":"The determination of the ratio of plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mature Plasma Cell to Total Cell Ratio Measurement","conceptCode":"C98869","definition":"The determination of the ratio of mature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"741BE03F-C8DC-64C4-E053-F662850AB651","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD3F-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MONOCE","valueDescription":null,"ValueMeaning":{"publicId":"6405785","version":"1","preferredName":"Monocytes to Total Cell Ratio Measurement","longName":"6405785","preferredDefinition":"The determination of the ratio of monocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monocytes to Total Cell Ratio Measurement","conceptCode":"C98872","definition":"The determination of the ratio of monocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E39F5B-68E9-4B4E-E053-F662850A699D","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD40-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EOSCE","valueDescription":null,"ValueMeaning":{"publicId":"6405787","version":"1","preferredName":"Eosinophils to Total Cell Ratio Measurement","longName":"6405787","preferredDefinition":"The determination of the ratio of eosinophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eosinophils to Total Cell Ratio Measurement","conceptCode":"C98720","definition":"The determination of the ratio of eosinophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E39F5B-690F-4B4E-E053-F662850A699D","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD41-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NEUTSGCE","valueDescription":null,"ValueMeaning":{"publicId":"11009267","version":"1","preferredName":"Segmented Neutrophil to Total Cell Ratio Measurement","longName":"11009267v1.00","preferredDefinition":"The determination of the ratio of segmented neutrophils to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Segmented Neutrophil to Total Cell Ratio Measurement","conceptCode":"C187679","definition":"The determination of the ratio of segmented neutrophils to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC101B-5C92-6E6E-E053-731AD00A3C67","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD42-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"RETICE","valueDescription":null,"ValueMeaning":{"publicId":"11009268","version":"1","preferredName":"Reticulocyte to Total Cell Ratio Measurement","longName":"11009268v1.00","preferredDefinition":"The determination of the ratio of reticulocytes to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reticulocyte to Total Cell Ratio Measurement","conceptCode":"C187680","definition":"The determination of the ratio of reticulocytes to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC1C9C-B1B6-6FBB-E053-731AD00A3EE4","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD43-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NEUTBCE","valueDescription":null,"ValueMeaning":{"publicId":"11009269","version":"1","preferredName":"Neutrophil Band Form to Total Cell Ratio Measurement","longName":"11009269v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutrophil Band Form to Total Cell Ratio Measurement","conceptCode":"C187701","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC1C9C-B1B7-6FBB-E053-731AD00A3EE4","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD44-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CEDISTR","valueDescription":null,"ValueMeaning":{"publicId":"11009270","version":"1","preferredName":"Cell Distribution Measurement","longName":"11009270v1.00","preferredDefinition":"An interpretive assessment of the proportion of various cell types in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell Distribution Measurement","conceptCode":"C187946","definition":"An interpretive assessment of the proportion of various cell types in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC1C9C-B1B8-6FBB-E053-731AD00A3EE4","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD45-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LYMPAGG","valueDescription":null,"ValueMeaning":{"publicId":"11009271","version":"1","preferredName":"Lymphoid Aggregates Measurement","longName":"11009271v1.00","preferredDefinition":"The determination of th lymphoid aggregates in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoid Aggregates Measurement","conceptCode":"C187947","definition":"The determination of th lymphoid aggregates in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC1C9C-B1B9-6FBB-E053-731AD00A3EE4","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD46-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TMDIFF","valueDescription":null,"ValueMeaning":{"publicId":"11009272","version":"1","preferredName":"Tumor Differentiation Assessment","longName":"11009272v1.00","preferredDefinition":"An evaluation of the tissue architecture of the tumor in comparison to the non-pathological tissue the tumor arose from.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Differentiation Assessment","conceptCode":"C187949","definition":"An evaluation of the tissue architecture of the tumor in comparison to the non-pathological tissue the tumor arose from.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC1C9C-B1BA-6FBB-E053-731AD00A3EE4","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD47-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TMINLPTN","valueDescription":null,"ValueMeaning":{"publicId":"11009273","version":"1","preferredName":"Tumor Infiltration Pattern Assessment","longName":"11009273v1.00","preferredDefinition":"An evaluation of the tumor infiltration pattern in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Infiltration Pattern Assessment","conceptCode":"C187950","definition":"An evaluation of the tumor infiltration pattern in a biological specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC29F7-4F92-7114-E053-731AD00A8923","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD48-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"TMBRDCFG","valueDescription":null,"ValueMeaning":{"publicId":"11009274","version":"1","preferredName":"Tumor Margin Configuration Assessment","longName":"11009274v1.00","preferredDefinition":"An evaluation of the morphologic appearance at the point where the tumor meets adjacent, non-tumor tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Margin Configuration Assessment","conceptCode":"C187951","definition":"An evaluation of the morphologic appearance at the point where the tumor meets adjacent, non-tumor tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC29F7-4F93-7114-E053-731AD00A8923","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD49-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LYMMCE","valueDescription":null,"ValueMeaning":{"publicId":"6407597","version":"1","preferredName":"Lymphoma Cell Count","longName":"6407597","preferredDefinition":"The determination of the number of lymphoma cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma Cell Count","conceptCode":"C74613","definition":"The determination of the number of lymphoma cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F427A1-402E-1B4B-E053-F662850A4A5F","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD4A-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"IRON","valueDescription":null,"ValueMeaning":{"publicId":"3654516","version":"1","preferredName":"Iron Measurement","longName":"3654516","preferredDefinition":"A measurement of the iron in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron Measurement","conceptCode":"C74679","definition":"The determination of the amount of iron present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3F85DFC-1826-2D6F-E040-BB89AD43138E","latestVersionIndicator":"Yes","beginDate":"2013-01-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-23","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD4B-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CELLULAR","valueDescription":null,"ValueMeaning":{"publicId":"6407498","version":"1","preferredName":"Cellularity Measurement","longName":"6407498","preferredDefinition":"The determination of the amount of degree, quality or condition of cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellularity Measurement","conceptCode":"C111153","definition":"The determination of the amount of degree, quality or condition of cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F40133-8271-2592-E053-F662850A81EB","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD4C-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MASTCECE","valueDescription":null,"ValueMeaning":{"publicId":"6412528","version":"1","preferredName":"Mast Cell to Total Cell Ratio Measurement","longName":"6412528","preferredDefinition":"The determination of the ratio of the mast cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mast Cell to Total Cell Ratio Measurement","conceptCode":"C111247","definition":"The determination of the ratio of the mast cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74316C4F-F4D3-0EBC-E053-F662850A0A3D","latestVersionIndicator":"Yes","beginDate":"2018-08-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-24","modifiedBy":"ONEDATA","dateModified":"2018-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD4D-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MERCECE","valueDescription":null,"ValueMeaning":{"publicId":"6407390","version":"1","preferredName":"Maturing Erythroid Cell to Total Cell Ratio Measurement","longName":"6407390","preferredDefinition":"The determination of the ratio of maturing erythroid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maturing Erythroid Cell to Total Cell Ratio Measurement","conceptCode":"C127628","definition":"The determination of the ratio of maturing erythroid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3A473-D99A-0770-E053-F662850AA0F7","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD4E-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMYCECE","valueDescription":null,"ValueMeaning":{"publicId":"6408035","version":"1","preferredName":"Proliferating Myeloid Cell to Total Cell Ratio Measurement","longName":"6408035","preferredDefinition":"The determination of the ratio of proliferating myeloid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferating Myeloid Cell to Total Cell Ratio Measurement","conceptCode":"C127634","definition":"The determination of the ratio of proliferating myeloid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F40133-84F8-2592-E053-F662850A81EB","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD4F-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GHISTXQL","valueDescription":null,"ValueMeaning":{"publicId":"11009264","version":"1","preferredName":"Qualitative Histopathologic Examination","longName":"11009264v1.00","preferredDefinition":"A general histopathologic examination, without a prespecified visual target, focused on qualitative or semi-quantitative findings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Qualitative Histopathologic Examination","conceptCode":"C147493","definition":"A general histopathologic examination, without a prespecified visual target, focused on qualitative or semi-quantitative findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC0355-B677-6CFC-E053-731AD00AF844","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD50-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BLASTCE","valueDescription":null,"ValueMeaning":{"publicId":"6403118","version":"1","preferredName":"Blasts to Total Cells Ratio Measurement","longName":"6403118","preferredDefinition":"The determination of the ratio of blasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blasts to Total Cells Ratio Measurement","conceptCode":"C150836","definition":"The determination of the ratio of blasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A912F3-5A79-4E20-E053-F662850AB063","latestVersionIndicator":"Yes","beginDate":"2018-08-18","endDate":null,"createdBy":"LUY","dateCreated":"2018-08-18","modifiedBy":"ONEDATA","dateModified":"2018-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD51-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LYMMCECE","valueDescription":null,"ValueMeaning":{"publicId":"8166849","version":"1","preferredName":"Lymphoma Cell to Total Cell Ratio Measurement","longName":"8166849","preferredDefinition":"The determination of the ratio of lymphoma cells to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma Cell to Total Cell Ratio Measurement","conceptCode":"C186078","definition":"The determination of the ratio of lymphoma cells to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC8AEC39-20BB-7CB7-E053-4EBD850A7B69","latestVersionIndicator":"Yes","beginDate":"2022-04-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-13","modifiedBy":"ONEDATA","dateModified":"2022-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD52-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MONOBLCE","valueDescription":null,"ValueMeaning":{"publicId":"11009265","version":"1","preferredName":"Monoblast to Total Cell Ratio Measurement","longName":"11009265v1.00","preferredDefinition":"The determination of the ratio of the monoblasts to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monoblast to Total Cell Ratio Measurement","conceptCode":"C187677","definition":"The determination of the ratio of the monoblasts to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC101B-5C90-6E6E-E053-731AD00A3C67","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD53-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PROMONCE","valueDescription":null,"ValueMeaning":{"publicId":"11009266","version":"1","preferredName":"Promonocyte to Total Cell Ratio Measurement","longName":"11009266v1.00","preferredDefinition":"The determination of the ratio of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen).The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Promonocyte to Total Cell Ratio Measurement","conceptCode":"C187678","definition":"The determination of the ratio of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen).The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5BC101B-5C91-6E6E-E053-731AD00A3C67","latestVersionIndicator":"Yes","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-08","modifiedBy":"KUMMEROA","dateModified":"2022-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD54-4085-E063-731AD00A53CD","beginDate":"2022-08-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PYKCE","valueDescription":null,"ValueMeaning":{"publicId":"11491778","version":"1","preferredName":"Pyknotic Cell Count","longName":"11491778v1.00","preferredDefinition":"The determination of the amount of pyknotic cells in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pyknotic Cell Count","conceptCode":"C189346","definition":"The determination of the amount of pyknotic cells in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBEFD87B-6E24-5F85-E053-731AD00AB3D6","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-26","modifiedBy":"KUMMEROA","dateModified":"2022-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD55-4085-E063-731AD00A53CD","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LNINNUM","valueDescription":null,"ValueMeaning":{"publicId":"11500116","version":"1","preferredName":"Number of Lymph Nodes Involved With Neoplastic Cells","longName":"11500116v1.00","preferredDefinition":"A measurement of the total number of lymph nodes that contain neoplastic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number of Lymph Nodes Involved With Neoplastic Cells","conceptCode":"C189620","definition":"A measurement of the total number of lymph nodes that contain neoplastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF54617-15A0-1883-E053-731AD00AF48B","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-26","modifiedBy":"KUMMEROA","dateModified":"2022-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD56-4085-E063-731AD00A53CD","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GOBCE","valueDescription":null,"ValueMeaning":{"publicId":"11500117","version":"1","preferredName":"Goblet Cell Count","longName":"11500117v1.00","preferredDefinition":"The determination of the amount of goblet cells present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Goblet Cell Count","conceptCode":"C189621","definition":"The determination of the amount of goblet cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF54617-15A1-1883-E053-731AD00AF48B","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-26","modifiedBy":"KUMMEROA","dateModified":"2022-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD57-4085-E063-731AD00A53CD","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GOBCEPIC","valueDescription":null,"ValueMeaning":{"publicId":"11500118","version":"1","preferredName":"Goblet Cell to Epithelial Cell Ratio Measurement","longName":"11500118v1.00","preferredDefinition":"The determination of the ratio of goblet cells to epithelial cells in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Goblet Cell to Epithelial Cell Ratio Measurement","conceptCode":"C189622","definition":"The determination of the ratio of goblet cells to epithelial cells in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBF54617-15A2-1883-E053-731AD00AF48B","latestVersionIndicator":"Yes","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-26","modifiedBy":"KUMMEROA","dateModified":"2022-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD58-4085-E063-731AD00A53CD","beginDate":"2022-10-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"HMCEADI","valueDescription":null,"ValueMeaning":{"publicId":"12920220","version":"1","preferredName":"Hematopoietic Cells to Adipocytes Ratio Measurement","longName":"12920220v1.00","preferredDefinition":"The determination of the ratio of hematopoietic cells to adipocytes present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cells to Adipocytes Ratio Measurement","conceptCode":"C191338","definition":"The determination of the ratio of hematopoietic cells to adipocytes present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F54E1A0A-5463-7232-E053-731AD00AEA03","latestVersionIndicator":"Yes","beginDate":"2023-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-02-22","modifiedBy":"KUMMEROA","dateModified":"2023-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD59-4085-E063-731AD00A53CD","beginDate":"2023-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"DPTHTINV","valueDescription":null,"ValueMeaning":{"publicId":"14086874","version":"1","preferredName":"Depth of Tumor Invasion","longName":"14086874v1.00","preferredDefinition":"An evaluation of the downward or inward extent of tumor invasion into a tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depth of Tumor Invasion","conceptCode":"C199982","definition":"An evaluation of the downward or inward extent of tumor invasion into a tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00B521AD-F2B6-3A38-E063-731AD00AE5D1","latestVersionIndicator":"Yes","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-17","modifiedBy":"KUMMEROA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD5B-4085-E063-731AD00A53CD","beginDate":"2023-07-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"EPISCECE","valueDescription":null,"ValueMeaning":{"publicId":"6413687","version":"1","preferredName":"Squamous Epithelial Cells to Total Cells Ratio Measurement","longName":"6413687","preferredDefinition":"The determination of the ratio of the squamous epithelial cells compared to the total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Epithelial Cells to Total Cells Ratio Measurement","conceptCode":"C132366","definition":"The determination of the ratio of the squamous epithelial cells compared to the total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"744BFE95-B786-1CB8-E053-F662850A612A","latestVersionIndicator":"Yes","beginDate":"2018-08-25","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-25","modifiedBy":"ONEDATA","dateModified":"2018-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD5C-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BCL2","valueDescription":null,"ValueMeaning":{"publicId":"14549073","version":"1","preferredName":"B-Cell Lymphoma 2 Measurement","longName":"14549073v1.00","preferredDefinition":"The determination of the amount of B-cell lymphoma 2 present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Cell Lymphoma 2 Measurement","conceptCode":"C201446","definition":"The determination of the amount of B-cell lymphoma 2 present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"082675FD-61AE-7C3A-E063-731AD00AB8EF","latestVersionIndicator":"Yes","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD5D-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ASGMGIND","valueDescription":null,"ValueMeaning":{"publicId":"14549074","version":"1","preferredName":"Adequate Surgical Margin Indicator","longName":"14549074v1.00","preferredDefinition":"An indication as to whether there is adequate distance of apparently non-tumorous tissue from the resected tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adequate Surgical Margin Indicator","conceptCode":"C201447","definition":"An indication as to whether there is adequate distance of apparently non-tumorous tissue from the resected tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"082675FD-61AF-7C3A-E063-731AD00AB8EF","latestVersionIndicator":"Yes","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD5E-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SGMGDIST","valueDescription":null,"ValueMeaning":{"publicId":"14549075","version":"1","preferredName":"Surgical Margin Distance Measurement","longName":"14549075v1.00","preferredDefinition":"A measurement of the distance from the tumor border to the surgical margin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Margin Distance Measurement","conceptCode":"C201448","definition":"A measurement of the distance from the tumor border to the surgical margin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"082675FD-61B0-7C3A-E063-731AD00AB8EF","latestVersionIndicator":"Yes","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD5F-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"INLNLNUM","valueDescription":null,"ValueMeaning":{"publicId":"14549076","version":"1","preferredName":"Number of Involved Lymph Node Levels","longName":"14549076v1.00","preferredDefinition":"A measurement of the number of levels of lymph nodes that contain neoplastic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Number of Involved Lymph Node Levels","conceptCode":"C201449","definition":"A measurement of the number of levels of lymph nodes that contain neoplastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"082675FD-61B1-7C3A-E063-731AD00AB8EF","latestVersionIndicator":"Yes","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD60-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"DEPTH","valueDescription":null,"ValueMeaning":{"publicId":"2753169","version":"1","preferredName":"Depth","longName":"2753169","preferredDefinition":"The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depth","conceptCode":"C25333","definition":"The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DEB1BF8-5D8D-1139-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-23","endDate":null,"createdBy":"UMLLOADER_AIM","dateCreated":"2008-05-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD61-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LENGTH","valueDescription":null,"ValueMeaning":{"publicId":"2753166","version":"1","preferredName":"Length","longName":"2753166","preferredDefinition":"The linear extent in space from one end of something to the other end, or the extent of something from beginning to end.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Length","conceptCode":"C25334","definition":"The linear extent in space from one end of something to the other end, or the extent of something from beginning to end.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DEB1BC8-9717-110B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-23","endDate":null,"createdBy":"UMLLOADER_AIM","dateCreated":"2008-05-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD62-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"WIDTH","valueDescription":null,"ValueMeaning":{"publicId":"2753168","version":"1","preferredName":"Width","longName":"2753168","preferredDefinition":"The extent or measurement of something from side to side.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Width","conceptCode":"C25345","definition":"The extent or measurement of something from side to side.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DEB1BEB-4E5D-112D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-23","endDate":null,"createdBy":"UMLLOADER_AIM","dateCreated":"2008-05-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3E89A8-FD63-4085-E063-731AD00A53CD","beginDate":"2023-10-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CD34SM","valueDescription":null,"ValueMeaning":{"publicId":"5076232","version":"1","preferredName":"CD34 Measurement","longName":"5076232","preferredDefinition":"A measurement of the CD34 expressing cells per unit in a biological specimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD34 Measurement","conceptCode":"C102260","definition":"The determination of the amount of CD34 expressing cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"265073B1-FFB9-E33F-E050-BB89AD43778F","latestVersionIndicator":"Yes","beginDate":"2015-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E711-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"GRANSGCE","valueDescription":null,"ValueMeaning":{"publicId":"6413423","version":"1","preferredName":"Segmented Granulocyte to Total Cell Ratio Measurement","longName":"6413423","preferredDefinition":"The determination of the ratio of segmented granulocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Segmented Granulocyte to Total Cell Ratio Measurement","conceptCode":"C127616","definition":"The determination of the ratio of segmented granulocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"744CADD3-ACF0-3097-E053-F662850A32F4","latestVersionIndicator":"Yes","beginDate":"2018-08-25","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-25","modifiedBy":"ONEDATA","dateModified":"2018-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E712-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"S100B","valueDescription":null,"ValueMeaning":{"publicId":"6413499","version":"1","preferredName":"S100 Calcium-Binding Protein B Measurement","longName":"6413499","preferredDefinition":"The determination of the amount of S100 calcium-binding protein B present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S100 Calcium-Binding Protein B Measurement","conceptCode":"C127635","definition":"The determination of the amount of S100 calcium-binding protein B present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"744D18AB-B64D-1F46-E053-F662850A9DB3","latestVersionIndicator":"Yes","beginDate":"2018-08-25","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-08-25","modifiedBy":"ONEDATA","dateModified":"2018-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E713-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ERPCECE","valueDescription":null,"ValueMeaning":{"publicId":"11159108","version":"1","preferredName":"Erythroid Precursor Cells to Total Cells Ratio Measurement","longName":"11159108v1.00","preferredDefinition":"The determination of the ratio of the erythroid precursors to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythroid Precursor Cells to Total Cells Ratio Measurement","conceptCode":"C187803","definition":"The determination of the ratio of the erythroid precursors to total cells present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E766697B-8789-3CAF-E053-731AD00A28A8","latestVersionIndicator":"Yes","beginDate":"2022-08-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-29","modifiedBy":"KUMMEROA","dateModified":"2022-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E714-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SCFR","valueDescription":null,"ValueMeaning":{"publicId":"14091611","version":"1","preferredName":"Mast/Stem Cell Growth Factor Receptor Kit Measurement","longName":"14091611v1.00","preferredDefinition":"The determination of the amount of amount of mast/stem cell growth factor receptor kit in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mast/Stem Cell Growth Factor Receptor Kit Measurement","conceptCode":"C199680","definition":"The determination of the amount of amount of mast/stem cell growth factor receptor kit in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00C3A8BB-DCB4-6E66-E063-731AD00A6C5B","latestVersionIndicator":"Yes","beginDate":"2023-07-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-18","modifiedBy":"KUMMEROA","dateModified":"2023-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E715-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"BCL6","valueDescription":null,"ValueMeaning":{"publicId":"14703082","version":"1","preferredName":"B-Cell Lymphoma 6 Protein Measurement","longName":"14703082v1.00","preferredDefinition":"The determination of the amount of B-cell lymphoma 6 protein in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Cell Lymphoma 6 Protein Measurement","conceptCode":"C202418","definition":"The determination of the amount of B-cell lymphoma 6 protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6EC-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E716-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CCND1","valueDescription":null,"ValueMeaning":{"publicId":"14703083","version":"1","preferredName":"Cyclin D1 Measurement","longName":"14703083v1.00","preferredDefinition":"The determination of the amount of cyclin D1 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cyclin D1 Measurement","conceptCode":"C202419","definition":"The determination of the amount of cyclin D1 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6ED-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E717-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CMYC","valueDescription":null,"ValueMeaning":{"publicId":"14703084","version":"1","preferredName":"c-Myc Measurement","longName":"14703084v1.00","preferredDefinition":"The determination of the amount of c-Myc in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"c-Myc Measurement","conceptCode":"C202420","definition":"The determination of the amount of c-Myc in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6EE-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E718-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"ITGB3","valueDescription":null,"ValueMeaning":{"publicId":"14703085","version":"1","preferredName":"Integrin Subunit Beta 3 Measurement","longName":"14703085v1.00","preferredDefinition":"The determination of the amount of integrin subunit beta 3 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integrin Subunit Beta 3 Measurement","conceptCode":"C202421","definition":"The determination of the amount of integrin subunit beta 3 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6EF-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E719-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"IRF4","valueDescription":null,"ValueMeaning":{"publicId":"14703086","version":"1","preferredName":"Interferon Regulatory Factor 4 Measurement","longName":"14703086v1.00","preferredDefinition":"The determination of the amount of interferon regulatory factor 4 protein in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interferon Regulatory Factor 4 Measurement","conceptCode":"C202422","definition":"The determination of the amount of interferon regulatory factor 4 protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F0-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E71A-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SOX10","valueDescription":null,"ValueMeaning":{"publicId":"14703087","version":"1","preferredName":"SRY-Box Transcription Factor 10 Measurement","longName":"14703087v1.00","preferredDefinition":"The determination of the amount of SRY-box transcription factor 10 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SRY-Box Transcription Factor 10 Measurement","conceptCode":"C202423","definition":"The determination of the amount of SRY-box transcription factor 10 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F1-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E71B-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"SCARD1","valueDescription":null,"ValueMeaning":{"publicId":"14703088","version":"1","preferredName":"Scavenger Receptor Class D, Member 1 Measurement","longName":"14703088v1.00","preferredDefinition":"The determination of the amount of scavenger receptor class D, member 1 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scavenger Receptor Class D, Member 1 Measurement","conceptCode":"C202424","definition":"The determination of the amount of scavenger receptor class D, member 1 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F2-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E71C-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"S100","valueDescription":null,"ValueMeaning":{"publicId":"14703089","version":"1","preferredName":"S100 Calcium Binding Protein Measurement","longName":"14703089v1.00","preferredDefinition":"The determination of the amount of S100 family of calcium binding proteins in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S100 Calcium Binding Protein Measurement","conceptCode":"C202425","definition":"The determination of the amount of S100 family of calcium binding proteins in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F3-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E71D-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"MLANA","valueDescription":null,"ValueMeaning":{"publicId":"14703090","version":"1","preferredName":"MART-1 Antigen Measurement","longName":"14703090v1.00","preferredDefinition":"The determination of the amount of melan-A in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MART-1 Antigen Measurement","conceptCode":"C202426","definition":"The determination of the amount of melan-A in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F4-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E71E-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"PMEL","valueDescription":null,"ValueMeaning":{"publicId":"14703091","version":"1","preferredName":"Melanocyte Protein PMEL Measurement","longName":"14703091v1.00","preferredDefinition":"The determination of the amount of premelanosome protein in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanocyte Protein PMEL Measurement","conceptCode":"C202427","definition":"The determination of the amount of premelanosome protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F5-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E71F-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LEU1","valueDescription":null,"ValueMeaning":{"publicId":"14703092","version":"1","preferredName":"T-Cell Surface Glycoprotein CD5 Measurement","longName":"14703092v1.00","preferredDefinition":"The determination of the amount of lymphocyte antigen T1/Leu-1 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD5 Measurement","conceptCode":"C202428","definition":"The determination of the amount of lymphocyte antigen T1/Leu-1 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F6-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E720-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LEU16","valueDescription":null,"ValueMeaning":{"publicId":"14703093","version":"1","preferredName":"Membrane Spanning 4-Domains A1 Measurement","longName":"14703093v1.00","preferredDefinition":"The determination of the amount of membrane spanning 4-domains A1 protein in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Membrane Spanning 4-Domains A1 Measurement","conceptCode":"C202429","definition":"The determination of the amount of membrane spanning 4-domains A1 protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F7-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E721-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"NCAM1","valueDescription":null,"ValueMeaning":{"publicId":"14703094","version":"1","preferredName":"Neural Cell Adhesion Molecule 1 Measurement","longName":"14703094v1.00","preferredDefinition":"The determination of the amount of neural cell adhesion molecule 1 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neural Cell Adhesion Molecule 1 Measurement","conceptCode":"C202430","definition":"The determination of the amount of neural cell adhesion molecule 1 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F8-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E722-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CD3TCM","valueDescription":null,"ValueMeaning":{"publicId":"14703095","version":"1","preferredName":"CD3 T-Cell Marker Measurement","longName":"14703095v1.00","preferredDefinition":"The determination of the amount of CD3 T-cell marker in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD3 T-Cell Marker Measurement","conceptCode":"C202431","definition":"The determination of the amount of CD3 T-cell marker in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6F9-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E723-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"LEU3","valueDescription":null,"ValueMeaning":{"publicId":"14703096","version":"1","preferredName":"T-Cell Surface Glycoprotein CD4 Measurement","longName":"14703096v1.00","preferredDefinition":"The determination of the amount of T-cell surface antigen T4/Leu-3 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD4 Measurement","conceptCode":"C202432","definition":"The determination of the amount of T-cell surface antigen T4/Leu-3 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6FA-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E724-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"CD8TGP","valueDescription":null,"ValueMeaning":{"publicId":"14703097","version":"1","preferredName":"T-Cell Surface Glycoprotein CD8 Measurement","longName":"14703097v1.00","preferredDefinition":"The determination of the amount of T-cell surface glycoprotein CD8 in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD8 Measurement","conceptCode":"C202433","definition":"The determination of the amount of T-cell surface glycoprotein CD8 in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3ECB03-E6FB-5570-E063-731AD00AE4CF","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3ECB03-E725-5570-E063-731AD00AE4CF","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6618618","version":"1","preferredName":"CDISC SDTM Microscopic Findings Test Code Terminology Code","preferredDefinition":"Terminology associated with the SDTM microscopic findings test code codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C132263:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC SDTM Microscopic Findings Test Code Terminology","conceptCode":"C132263","definition":"Terminology associated with the SDTM microscopic findings test code codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"803BED72-AB6F-74F6-E053-F662850A6CF9","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F3E89AC-E432-4081-E063-731AD00A69D8","latestVersionIndicator":"Yes","beginDate":"2019-01-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-02-13","changeDescription":"2022-4-13 ak Versioned to reflect update to Pkg 49. 2022-1-12 ak Updated to CT Package 48 release. 2021-10-14 ak Updated to CT Package 47 release. 2021-7-15 ak Updated to CT Package 46 release. 2021-4-16 ak Updated to CT Package 45 release. 2021-1-12 ak Updated to CT Package 44 release. 2020-9-29 ak Updated to CT Package 43 release. 4/2/20 Updated to pkg 40; tmt. 1/24/19 TMT created for SDTM standardization. VD reviewed and released 3/3/2022, wz","administrativeNotes":"2024.2.13 Released per WZ review. ak 2024.1.18 Versioned to reflect CT Pkg 56 updates. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6338162","version":"1","longName":"CDISC (NCI Implementation)","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7218795","version":"1","longName":"SDTM","context":"NCI Standards"},{"publicId":"10000098","version":"1","longName":"Microscopic Findings (MI) Domain","context":"NCI Standards"}]}],"AlternateNames":[{"name":"MI.MITESTCD","type":"Map:SDTM IGv3.2","context":"NCIP"}],"ReferenceDocuments":[{"name":"Required","type":"SDTM Core","description":"Required","url":null,"context":"NCI Standards"},{"name":"PQT","type":"Preferred Question Text","description":"Microscopic Examination Short Name","url":null,"context":"NCI Standards"},{"name":"CDISC SDTM Microscopic Findings Test Code Terminology","type":"VALID_VALUE_SOURCE","description":"Terminology associated with the SDTM microscopic findings test code codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).","url":"https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C132263","context":"NCI Standards"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Test Code","url":null,"context":"Theradex"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F3EA789-018F-45DC-E063-731AD00A0A35","latestVersionIndicator":"Yes","beginDate":"2019-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-02-13","changeDescription":"2022-4-13 ak Versioned due to update to CT Package 49 release. 1-30-19 Curated to support CDISC Initiative; tmt.","administrativeNotes":"2024.2.13 Released per WZ review. ak 2024.1.18 Versioned to reflect update to CT Package 56 release.  ak","unresolvedIssues":null,"deletedIndicator":"No"}}